Menu Search
Equities

Tilray Brands Inc

TLRY:NSQ

Tilray Brands Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.78
  • Today's Change-0.02 / -1.11%
  • Shares traded176.83k
  • 1 Year change-27.64%
  • Beta2.1374
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Tilray Brands Inc grew revenues 25.80% from 627.12m to 788.94m while net income improved from a loss of 1.45bn to a smaller loss of 244.98m.
Gross margin28.31%
Net profit margin-28.19%
Operating margin-22.15%
Return on assets-5.22%
Return on equity-7.25%
Return on investment-5.72%
More ▼

Cash flow in USDView more

In 2024, Tilray Brands Inc increased its cash reserves by 10.51%, or 21.71m. Cash Flow from Investing totalled 128.35m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 30.91m for operations while cash used for financing totalled 75.19m.
Cash flow per share-0.1286
Price/Cash flow per share--
Book value per share4.14
Tangible book value per share0.6233
More ▼

Balance sheet in USDView more

Tilray Brands Inc has a Debt to Total Capital ratio of 9.63%, a lower figure than the previous year's 10.79%.
Current ratio2.27
Quick ratio1.42
Total debt/total equity0.1066
Total debt/total capital0.0963
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.